Yiping Qu

1.5k total citations
37 papers, 1.1k citations indexed

About

Yiping Qu is a scholar working on Molecular Biology, Cancer Research and Clinical Biochemistry. According to data from OpenAlex, Yiping Qu has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Clinical Biochemistry. Recurrent topics in Yiping Qu's work include Epigenetics and DNA Methylation (6 papers), RNA modifications and cancer (6 papers) and Metabolism and Genetic Disorders (5 papers). Yiping Qu is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), RNA modifications and cancer (6 papers) and Metabolism and Genetic Disorders (5 papers). Yiping Qu collaborates with scholars based in China, United States and Nigeria. Yiping Qu's co-authors include Peng Hou, Siwen Dang, Meiju Ji, Qi Yang, Bingyin Shi, Yuan Shao, Bingyin Shi, Bowen Yao, Fang Sui and Simeng Wang and has published in prestigious journals such as ACS Nano, Chemistry of Materials and Advanced Functional Materials.

In The Last Decade

Yiping Qu

37 papers receiving 1.0k citations

Peers

Countries citing papers authored by Yiping Qu

Since Specialization

Citations

This map shows the geographic impact of Yiping Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiping Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiping Qu more than expected).

Fields of papers citing papers by Yiping Qu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiping Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiping Qu. The network helps show where Yiping Qu may publish in the future.

Co-authorship network of co-authors of Yiping Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Yiping Qu. A scholar is included among the top collaborators of Yiping Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiping Qu. Yiping Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High expression of RTEL1 predicates worse progression in gliomas and promotes tumorigenesis through JNK/ELK1 cascade 2024 ·BMC Cancer ·Guanjie Wang, (unknown), Jianying Li, (unknown), (unknown), Fang Sui, (unknown), Pu Chen, Qi Yang, Meiju Ji, Peng Hou, Ke Gao, Yiping Qu	5
2	Boosting the proton conduction in a magnetic dysprosium-organic framework by introducing conjugate NH4+-NH3 pairs 2023 ·Chinese Chemical Letters ·Yiping Qu, Qian Zou, Song‐Song Bao, Li‐Min Zheng	16
3	Octahedral lanthanide clusters containing a central PO₄³⁻ anion: structural, luminescent, magnetic and relaxometric properties 2023 ·Dalton Transactions ·Yiping Qu, Xin‐Da Huang, Kui Xu, Song‐Song Bao, Li‐Min Zheng	8
4	Cohesin <b><i>RAD21</i></b> Gene Promoter Methylation Correlated with Better Prognosis in Breast Cancer Patients 2022 ·Cytogenetic and Genome Research ·(unknown), Pu Chen, Yuanyuan Wang, (unknown), Meiju Ji, Peng Hou, Yiping Qu	2
5	Promoter methylation of transient receptor potential melastatin-related 7 (TRPM7) predicts a better prognosis in patients with Luminal A breast cancers 2022 ·BMC Cancer ·Yuanyuan Wang, (unknown), Pu Chen, (unknown), Meiju Ji, Xiaozhi Zhang, Peng Hou, Yiping Qu	5
6	Identification of a germline CSPG4 variation in a family with neurofibromatosis type 1-like phenotype 2021 ·Cell Death and Disease ·(unknown), Yiping Qu, (unknown), (unknown), Zhèn Yáng, Meiju Ji, Peng Hou	2
7	HACE1-mediated NRF2 activation causes enhanced malignant phenotypes and decreased radiosensitivity of glioma cells 2021 ·Signal Transduction and Targeted Therapy ·(unknown), Jun Pu, Zhe Liu, Jing Wei, Yiping Qu, (unknown), Bingyin Shi, Jian Yang, Nongyue He, Peng Hou	21
8	Chinese expert brief consensus on newborn screening of inherited metabolic disorders during the novel coronavirus infection epidemic 2020 ·Annals of Translational Medicine ·Shan Liu, Dongjuan Wang, (unknown), Hao Liu, Dayong Zhang, Jing Yang, (unknown), Xiaoyan He, (unknown), (unknown), (unknown), Yiping Qu, (unknown), Weipeng Wang, (unknown), (unknown), Shuodan Huang, Zhiguo Wang, (unknown)	7
9	Turning a Luffa Protein into a Self-Assembled Biodegradable Nanoplatform for Multitargeted Cancer Therapy 2018 ·ACS Nano ·Wangxiao He, Jin Yan, Fang Sui, Simeng Wang, Xi Su, Yiping Qu, (unknown), Hui Guo, Meiju Ji, Wuyuan Lu, Yongping Shao, Peng Hou	46
10	SIRT7 promotes thyroid tumorigenesis through phosphorylation and activation of Akt and p70S6K1 via DBC1/SIRT1 axis 2018 ·Oncogene ·Heng Li, (unknown), Yiping Qu, Qi Yang, Haixia Guan, Bingyin Shi, Meiju Ji, Peng Hou	51
11	Lipoamide Inhibits NF1 Deficiency-induced Epithelial-Mesenchymal Transition in Murine Schwann Cells 2017 ·Archives of Medical Research ·Yuchen Zhang, (unknown), Yiping Qu, Maoguo Shu, Shuzhong Guo, (unknown)	9
12	c-Myc is Required for BRAF^V600E-Induced Epigenetic Silencing by H3K27me3 in Tumorigenesis 2017 ·Theranostics ·Yiping Qu, Qi Yang, Juan Liu, Bingyin Shi, Meiju Ji, Gang Li, Peng Hou	30
13	Activated ERK: An Emerging Player in miRNA Downregulation 2017 ·Trends in cancer ·Yiping Qu, Bingyin Shi, Peng Hou	8
14	A Strategy for Accurate Quantification of 5-Methylcytosine and 5-Hydroxymethylcytosine at CpG Sites Within Gene Promoter 2014 ·Journal of Biomedical Nanotechnology ·Yiping Qu, Qi Yang, Fang Sui, Rong Lu, Siwen Dang, Meiju Ji, Nongyue He, Bingyin Shi, Peng Hou	4
15	[Methylation analysis of CpG island DNA of FMR1 gene in the fragile X syndrome]. 2013 ·PubMed ·(unknown), (unknown), Zhengyan Zhao, Yiping Qu, (unknown)	2
16	Variable copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in advanced gastric cancer patients 2013 ·Diagnostic Pathology ·Guanjun Zhang, Yiping Qu, Siwen Dang, Qi Yang, Bingyin Shi, Peng Hou	36
17	MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6 2013 ·Cancer Cell International ·Yuan Shao, Yiping Qu, Siwen Dang, Bowen Yao, Meiju Ji	94
18	Gene methylation in gastric cancer 2013 ·Clinica Chimica Acta ·Yiping Qu, Siwen Dang, Peng Hou	301
19	Diagnosis and treatment of subclinical hypothyroidism detected by neonatal screening 2011 ·World Journal of Pediatrics ·Xiaoxiao Chen, Yufeng Qin, Xuelian Zhou, Rulai Yang, (unknown), (unknown), Yiping Qu, Xu Wang, (unknown)	4
20	DNA methylation damage in individuals at high risk for stomach cancer 1992 ·Mutation Research/Environmental Mutagenesis and Related Subjects ·Donald P. Cooper, (unknown), Yiping Qu, Patrick J. O’Connor	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact